Posted on Jul 12, 2012

Dr. Kevin Kip presents at SER Annual Meeting on the protection and risk of psoriasis using Crohn’s disease biologic agents

Kip, E. K., Swoger, M. J., Grandinetti, M. L., Barrie III, M. A., Greer, B. J., Regueiro, D. M. (2012, June). Protection Versus Risk of Psoriasis with Use of Crohn’s Disease Biologic Agents: An Analysis of the FDA Adverse Event Reporting System (AERS). Oral presentation at the Society of Epidemiologic Research (SER) Annual Meeting in Minneapolis, Minnesota.